Clinical • PD(L)-1 Biomarker • IO biomarker
|
HLA-A (Major Histocompatibility Complex, Class I, A) • PD-1 (Programmed cell death 1) • HAVCR2 (Hepatitis A Virus Cellular Receptor 2) • CTAG1B (Cancer/testis antigen 1B) • IL2 (Interleukin 2)
|
HAVCR2 expression • HLA-A*02 • HLA-A2 positive • PD-1 positive
|
NY-ESO-1 combined with MPLA vaccine